1--gmt-pres english-mstr

GlobalMed Technologies Inc.

Medical Technologies for the Future Generation

A Company dedicated to the Treatments and Cure

of Catastrophic Diseases

Who is GlobalMed Tech, (GMT)

• GMT is a Bio Medical Technology Company.• GMT has developed a treatment modality which

effectively inactivates the HIV virus.• GMT has Government approval to conduct Controlled

Clinical Trials on 100 subjects in South America.• GMT has patented it’s process and products

worldwide. • GMT Manufactures 5 Main Components:• PCI-1 Hemoirradiator• The GMT - Electronic Master Control Card• GMT Proprietary Software• Patient Intelli - Flash drive Software• The GMT – Cuvette, ( Irradiation Chamber )

PCITHE PROCESS OF HEMOIRRADIATION.

• PCI IS THE PROCESS OF EXPOSING A CERTAIN QUANTITY OF BLOOD TO ULTRAVIOLET IRRADIATION VIA A STERILE CLOSED CIRCUIT, CALLED A CUVETTE OR IRRADIATION CHAMBER.

• THE BLOOD NEVER COMES IN CONTACT WITH THE AMBIENT ENVIRONMENT.

FUNCTION• AS IN ANY FORM OF THERAPY, THE SUCCESS

OF HEMOIRRADIATION IS DEPENDANT ON THE DOSAGE ADMINISTERED.

• AND• THE CURATIVE PROPERTIES IN VIVO IS

DERIVED FROM THE ACTIVATION AND STIMULATORY EFFECT UPON CELLS AND MOLECULES WHICH COMPOSE HUMAN BLOOD.

NIELS FINSEN

• FATHER OF PHOTOTHERAPY:

• Won Nobel Prize in Physiology & Medicine in 1903 “In recognition of his contribution to the treatment of diseases, especially Lupus Vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science“ 

• Dr. Finsen’s contribution to medicine is unparallel. He treated 300 patients with Lupus Vulgaris and demonstrated, 100% success rates. Today, we have nothing in our arsenal of medications that can produce such results. 

Lester Edblom, medical student and Dr. Emmet Knott scientist, developed the first Hemoirradiator vacuum extraction system and Cuvette. The first Patent was issued in the US for a UV-Irradiator. September 11, 1928.Thousands of people were treated between the 1930’s up to 1969 with a 98% success rate..

Emmet Knott Irradiator.

EUMATRON

HEMOIRRADIATOR FROM GERMANY.

UTILIZED IN THOUSANDS OF MEDICAL CENTERS

IN EUROPE.

PTX4PHOTONIC PUMP

USA.NOT-FDA APPROVEDUTILIZED IN VARIOUS

ALTERNATIVE CENTERS IN THE

US

Baxter Fenwal Plasma

Separator. Utilized in the treatment of Scleroderma In San Vicente

Hospital Medellin, Colombia.

Treatment of Scleroderma -LupusTime of Tx. 5 hours. Cost: 2,000 to 2,500

US

THERAKOSJOHNSON & JOHNSON

Ultraviolet A Irradiator

Irradiator developed by Dr. Elderson and

utilized in clinical trials on AIDS Related ARC patients at Columbia University in 1990. Four subjects were registered as SERO

Negative after 5 to 19 Sessions.

Therakos. Time of Tx. 5 hours. Cost: 5,000 US

GlobalMed Technologies:

• PCI-1 Hemoirradiator• GMT- Cuvette (Irradiation Chamber)• Electronic Master Control Card• Electronic UV Detector• GMT Proprietary Software• Patient Inteli - Flash drive Software

PCI-1 GLOBALMEDTime of Tx. 25 minutes Cost: $75.00 )

GMT-PCI-1Bar Code Scanner

UVC Irradiation Bulb

Automatic Peristalsis Pump

Inteliflash-Card

LCD

Keyboard

UV protection Lid

GMT-Cuvette

Utilized during Treatments.Developed and Manufactured by

GMT.Patent Registered Worldwide.

GMT -Cuvette (Irradiation Chamber)

Prototype

Blood Banks

Human

GMT -Cuvette (Irradiation Chamber)

Quartz Glass

External Body

Top

O-Ring 1

O-Ring 2

GMT –Kit

Hep-Loc IV Catheter Placement.,

Used to extract and re infuse patients blood during

treatment.

Placement of

GMT-Hep-Loc

Blood Extraction

Process• Patient sits comfortably and may watch television, read or listen to music during their sessions.

•Up to 300ml of blood is extracted.

• Time of Treatment: Extraction 7-10 min.

Irradiation 5 minRe Infusion 7-10 min

• Total Time : 19-25 min

Commencement of Treatment. Blood begins to

enter Cuvette.

Irradiation Process.The blood is propelled by the Peristaltic

Pump via the Irradiation Chamber (Cuvette) where the blood is irradiated with the precise amount of UV Dosage. After irradiation the blood continues to

the secondary Blood Bag and from there is returned via a Blood Administration Kit

with a 70um Filter.

Re-Infusion Process

Government Approved Clinical Study in the

Republic Dominican with 36 Patients living with

HIV/AIDS

TREATMENT PROCESS GMT. PROCESS OF BLOOD EXTRACTION.

GlobalMed

Process of

IrradiationTime: 25 minutes

Cost $75.00 US/Kit.

TREATMENT CENTER

Bacterial Membrane Destruction

UV destroys a Bacteria's Membrane there by Inactivating the Bacteria

Before After

Virus Destruction

2 Hours 4 Hours 6 Hours

The destruction of a Virus is achieved by Fragmentation which Inactivates the

Virus.

Destruction of Fungus

The Destruction of Fungus is achieved by the Photo-Oxidation effect on their

Membranes which prohibits Biosynthesis.

Before 24 Hours 48 Hours

PROTOCOL ISUV-001-04

CLASSIFICATION BY AGE AGE GROUP SUBJECTS

18 – 30 1231 – 40 1641 – 51 8 TOTAL: 36

PROTOCOLO ISUV-001-04 STUDY DECREASE PROGRESSION

VIRAL LOAD VIRAL LOAD• ROCHE 116A (8 WEEKS) 52% 48%• ROCHE 116A (16 WEEKS) 46% 54%• ROCHE 116B/117 (8 WEEKS) 55% 45%• ROCHE 116B/117 (16 WEEKS) 55% 45%

• GMT-PCI 2004-001 (4 WEEKS) 58% 42%• GMT-PCI 2004-001 (8 WEEKS) 76% 24%• GMT-PCI 2004-001 (12 WEEKS) 84% 16%

GMT PCI REGIMENT COMPARED TO A DOUBLE BRANCH STUDY PERFORMED BY

ROCHE , UTILIZING RETROVIRAL REGIMENT OF ZDV, AND ddl.

BEFORE AND AFTER PHOTOS.AFTER 90 DAYS OF TREATMENT, 100% OF OPPORTUNISTIC INFECTIONS HAD

SUBSIDED.GMT believes it can reduce the cost to keep one HIV/AIDS patient alive by 90% a year.

Savings to Medicare and Medicaid would be in the Billions.

Current Across the Board yearly cost in US to keep 1 million HIV/AIDS patients alive = 20 Billion

Estimated cost with GMT Protocol 1 million patients

1.5 to 2 Billion

PRE TREATMENTPRE TREATMENT AFTER 2 AFTER 2 TREATMENTS.TREATMENTS.

WEEK 2WEEK 2

AFTER 4 AFTER 4 TREATMENTS.TREATMENTS.

WEEK 4WEEK 4

AFTER 2 TREATMENTS (WEEK 2)AFTER 2 TREATMENTS (WEEK 2)PRE TREATMENTPRE TREATMENT

PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)

PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)

AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)PRE TREATMENTPRE TREATMENT

PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)

PRE TREATMENTPRE TREATMENT AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2) (WEEK 2)

AFTER 2 TREATMENTS AFTER 2 TREATMENTS (WEEK 2)(WEEK 2)PRE TREATMENTPRE TREATMENT